术前影像学表现预测胆道闭锁患者Kasai术后2年自体肝生存
回顾性纳入90例胆道闭锁Kasai术前接受超声和/或MRI的患者,52%(47/90)出现Kasai失败。超声胆囊长度(截断值1.6 cm,AUC 67.66)和胆管囊肿(OR 24.64)为显著预测因子,联合准确率73%(60/82);同时有超声和MRI者联合准确率85%(52/61)。
要点
- 超声示胆囊长度<1.6 cm、肝动脉直径>2 mm、无胆管囊肿提示Kasai失败风险升高。
- MRI示胆囊长度<1.2 cm、脾脏大小>6.9 cm亦为Kasai失败的显著预测因子。
- 超声与MRI联合预测2年自体肝生存的准确率达85%(52/61)。
核心结论
- 术前超声和/或MRI可增强胆道闭锁患者Kasai术后2年自体肝生存的预测能力。
研究设计与样本
- 回顾性研究纳入2000至2020年间接受Kasai手术且有术前超声和/或MRI的胆道闭锁患者,排除随访不足2年者;最终纳入90例(全部有术前超声,61例同时有MRI),采用多变量逻辑回归分析筛选预测2年自体肝生存的影像指标。
关键影像表现/征象
- 超声示肝动脉直径>2 mm(截断值,AUC 73.83)与胆管囊肿(OR 23.89,95%CI 1.43-398.82,p=0.027)为同时有超声和MRI患者的显著预测因子。
- 超声示胆囊长度<1.6 cm(截断值,AUC 67.66)与胆管囊肿(OR 24.64,95%CI 1.97-308.08,p=0.013)为全部超声患者的显著预测因子。
- MRI示胆囊长度<1.2 cm(截断值,AUC 74.72)与脾脏大小>6.9 cm(截断值,AUC 73.72)为同时有超声和MRI患者的显著预测因子。
诊断标准与关键数值
- 超声胆囊长度截断值1.6 cm,AUC 67.66(全部超声患者)。
- 超声肝动脉直径截断值2 mm,AUC 73.83(同时有超声和MRI患者)。
- MRI胆囊长度截断值1.2 cm,AUC 74.72;MRI脾脏大小截断值6.9 cm,AUC 73.72(同时有超声和MRI患者)。
- 超声联合预测准确率73%(60/82);超声与MRI联合预测准确率85%(52/61)。
临床应用与阅片要点
- 术前超声测量胆囊长度、肝动脉直径及有无胆管囊肿,可辅助预判Kasai术后2年自体肝生存概率。
- 同时有术前MRI者,可补充测量胆囊长度和脾脏大小,联合超声提高预测准确率至85%(52/61)。
- 肝动脉直径>2 mm(超声)、胆囊长度<1.6 cm(超声)或<1.2 cm(MRI)、脾脏大小>6.9 cm(MRI)及无胆管囊肿(超声/MRI)提示2年自体肝生存可能性降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the feasibility of using preoperative imaging indices to predict 2-year native liver survival after the Kasai procedure in patients with biliary atresia (BA).
MATERIALS AND METHODS: The retrospective review included 190 BA patients who underwent the Kasai procedure between 2000 and 2020, with preoperative US and/or MRI, excluding cases with less than 2-year follow-up period. Multivariable logistic regression analysis was performed to identify imaging indices to predict 2-year native liver survival. Kasai failure was defined as the need for liver transplantation or death within 2 years of the Kasai procedure.
RESULTS: Of the 90 patients included, all had preoperative US, and 61 also had MRI. Kasai failure occurred in 52% (47/90). Preoperative US identified gallbladder length (OR 0.40, 95% CI 0.17-0.95, p = 0.039; cutoff 1.6 cm, AUC 67.66) and biliary cysts (OR 24.64, 95% CI 1.97-308.08, p = 0.013) as significant Kasai failure predictors, with a combined accuracy of 73% (60/82). For patients having both preoperative US and MRI, significant predictors were hepatic artery diameter (OR 6.75, 95% CI 1.31-34.88, p = 0.023; cutoff 2 mm, AUC 73.83) and biliary cysts (OR 23.89, 95% CI 1.43-398.82, p = 0.027) on US, and gallbladder length (OR 0.25, 95% CI 0.08-0.76, p = 0.014; cutoff 1.2 cm, AUC 74.72) and spleen size (OR 2.53, 95% CI 1.02-6.29, p = 0.045; cutoff 6.9 cm, AUC 73.72) on MRI, with a combined accuracy of 85% (52/61).
CONCLUSION: Preoperative US and/or MRI enhance the 2-year native liver survival prediction in BA patients after the Kasai procedure.
CLINICAL RELEVANCE STATEMENT: BA patients with hepatic artery diameter > 2 mm (US), gallbladder length < 1.6 cm (US) or < 1.2 cm (MRI), spleen size > 6.9 cm (MRI), and absence of biliary cysts (US/MRI) have a decreased likelihood of 2-year native liver survival.
KEY POINTS: • Preoperative US and/or MRI can predict the probability of achieving 2-year native liver survival following the Kasai procedure. • Combining US and MRI improved the accuracy to 85% for predicting 2-year native liver survival in BA patients. • The hepatic artery diameter > 2 mm (US), gallbladder length < 1.6 cm (US) or < 1.2 cm (MRI), spleen size > 6.9 cm (MRI), and no biliary cysts (US/MRI) are significant predictors of Kasai failure in patients with biliary atresia.
引用
- Kim H, Yoo SY, Kim JH, et al. Preoperative imaging findings to predict 2-year native liver survival after the Kasai procedure in patients with biliary atresia. Eur Radiol. 2023. PMID: 37646810. doi:10.1007/s00330-023-10055-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。